Epidemiology, management and outcomes of Graves' disease-real life data.
Y S HussainJ C HookhamA AllahabadiaSabapathy P BalasubramanianPublished in: Endocrine (2017)
In the follow-up, 39.9% of patients underwent surgery or radio-iodine ablation with little morbidity. Up to two-thirds of patients who achieved remission did not relapse. Data on effectiveness and risks of treatments for Graves' disease presented in this study will help clinicians and patients in decision making.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- randomized controlled trial
- decision making
- prognostic factors
- type diabetes
- minimally invasive
- magnetic resonance imaging
- machine learning
- risk factors
- patient reported outcomes
- big data
- atrial fibrillation
- rheumatoid arthritis
- acute coronary syndrome
- weight loss
- insulin resistance
- artificial intelligence
- patient reported
- human health
- catheter ablation